Baseline blood pressure modifies the role of blood pressure variability in mortality: Results from the ACCORD trial

@article{Nuyujukian2022BaselineBP,
  title={Baseline blood pressure modifies the role of blood pressure variability in mortality: Results from the ACCORD trial},
  author={Daniel S. Nuyujukian and Michelle Newell and Jin J. Zhou and Juraj Koska and Peter D. Reaven},
  journal={Diabetes},
  year={2022},
  volume={24},
  pages={951 - 955}
}
Previous studies indicate that visit-to-visit blood pressure variability (BPv), independent of mean blood pressure level, is associated with adverse cardiovascular outcomes and mortality. These findings have included cohorts both with and without diabetes. In a recent meta-analysis of patients with type 2 diabetes (T2D), a significant 12% increase in all-cause mortality was linked to systolic BPv. A more recent body of literature suggests that associations between BPv and risk of nonfatal… 

References

SHOWING 1-10 OF 23 REFERENCES
Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT
TLDR
Blood pressure variability is associated with HF risk in individuals with type 2 diabetes, possibly a consequence of periods of ischemia during diastole, and may have implications for optimizing blood pressure treatment strategies in those with type 1 diabetes.
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality
TLDR
A secondary data analysis of ALLHAT was conducted to examine whether VVV of BP is associated with CVD and mortality events and found patients with greater visit-to-visit variability in BP readings had an increased risk for cardiovascular events and mortality.
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.
Refining determinants of associations of visit-to-visit blood pressure variability with cardiovascular risk: results from the Action to Control Cardiovascular Risk in Diabetes Trial
TLDR
The effect of BPv on adverse cardiovascular (but not cerebrovascular) outcomes is modified by baseline blood pressure and prior CVD, and recognition of more nuanced relationships may help improve risk stratification and blood pressure management decisions.
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
TLDR
Diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects, and associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group and prior vascular disease and cardiovascular disease risk factors.
New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk
TLDR
As epidemiologic evidence increases in support of a role for metabolic risk factor variability in cardiovascular risk, there is a corresponding rise in interest in applying this information toward improving risk factor prediction and treatment.
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
TLDR
Higher visit-to-visit systolic blood pressure variability is associated with increased risk of cardiovascular events in patients with hypertension, irrespective of baseline risk ofiovascular events.
Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study
TLDR
AASI is a novel measure of arterial stiffness, which can be readily determined from ambulatory blood pressure recordings and which independently predicts cardiovascular mortality, even in normotensive subjects.
Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?
TLDR
In the elderly hypertensives, strict BP control using CCBs could play a pivotal role in suppressing arterial stiffening via VVV reduction.
...
...